# Safety and Efficacy of FAP iCDC in Acute Myocardial Infarction With Cardiogenic Shock

> **NCT07380659** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Second Affiliated Hospital, School of Medicine, Zhejiang University** · enrollment: 18 (estimated)

## Conditions studied

- Cardiogenic Shock
- Cardiogenic Shock Post Myocardial Infarction
- STEMI - ST Elevation Myocardial Infarction

## Interventions

- **BIOLOGICAL:** FAP allogeneic immunosuppressive CAR-DC

## Key facts

- **NCT ID:** NCT07380659
- **Lead sponsor:** Second Affiliated Hospital, School of Medicine, Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-20
- **Primary completion:** 2027-01-30
- **Final completion:** 2027-02-28
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2026-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07380659

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07380659, "Safety and Efficacy of FAP iCDC in Acute Myocardial Infarction With Cardiogenic Shock". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT07380659. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*